| Entry |
|
|---|
| Name |
Anthralin (USP);
Dithranol (INN);
Anthraderm (TN) |
|---|
| Formula |
C14H10O3
|
|---|
| Exact mass |
226.063
|
|---|
| Mol weight |
226.2274
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antipsoriatic |
|---|
| Disease |
|
|---|
| Comment |
See C06831 (tautomer)
Antracen derivative
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D05 ANTIPSORIATICS
D05A ANTIPSORIATICS FOR TOPICAL USE
D05AC Antracen derivatives
D05AC01 Dithranol
D00233 Anthralin (USP)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C8y C 26.1340 -18.2111
2 C8y C 26.1397 -16.8124
3 C5x C 27.3405 -18.9165
4 C8y C 24.9275 -18.9106
5 C1x C 27.3520 -16.1131
6 C8x C 24.9275 -16.1071
7 C8y C 28.5528 -18.2171
8 O5x O 27.3405 -20.3154
9 C8x C 23.7093 -18.2111
10 O1a O 24.9275 -20.3095
11 C8y C 28.5645 -16.8241
12 C8x C 23.7093 -16.8124
13 C8y C 29.7593 -18.9282
14 C8x C 29.7827 -16.1305
15 C8x C 30.9776 -18.2404
16 O1a O 29.7244 -20.3271
17 C8x C 30.9892 -16.8415
BOND 19
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 2
9 4 10 1
10 5 11 1
11 6 12 2
12 7 13 2
13 11 14 2
14 13 15 1
15 13 16 1
16 14 17 1
17 7 11 1
18 9 12 1
19 15 17 2
|
|---|
